Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients.
暂无分享,去创建一个
M. Volpe | H. Neuberger | P. Bramlage | M. Thoenes | S. Gräber | J. Reil | M. Böhm
[1] D. Mikhailidis,et al. Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. , 2008, International journal of cardiology.
[2] D. Wilber,et al. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. , 2008, Journal of the American College of Cardiology.
[3] A. Goette,et al. Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression , 2008, Circulation.
[4] M. Böhm,et al. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH , 2008, Journal of hypertension.
[5] M. Böhm,et al. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study , 2007, Journal of hypertension.
[6] Jean-Claude Tardif,et al. Resting heart rate in cardiovascular disease. , 2007, Journal of the American College of Cardiology.
[7] M. Böhm,et al. The role of heart rate in the development of cardiovascular disease , 2007, Clinical Research in Cardiology.
[8] P. Vardas,et al. Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. , 2007, The American journal of cardiology.
[9] W. Stevenson,et al. Management of atrial fibrillation in patients with heart failure. , 2007, Heart rhythm.
[10] A. Hofman,et al. Subclinical atherosclerosis and risk of atrial fibrillation: the rotterdam study. , 2007, Archives of internal medicine.
[11] H. Parving,et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. , 2006, Kidney international.
[12] Giuseppe Mancia,et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. , 2006, Journal of hypertension.
[13] M. P. van den Berg,et al. C-reactive protein and microalbuminuria are associated with atrial fibrillation. , 2005, International journal of cardiology.
[14] F. Veglia,et al. The REassessment of Antihypertensive Chronic Therapy (REACT) Study , 2004 .
[15] L. Bouter,et al. Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study. , 2004, Kidney international. Supplement.
[16] G. Reboldi,et al. Hypertension and microalbuminuria: the new detrimental duo , 2004, Blood pressure.
[17] G. Mensah,et al. Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention , 2003, Circulation.
[18] L. Ruilope,et al. Is it time to measure microalbuminuria in hypertension? , 2003, Journal of hypertension.
[19] H. Janka,et al. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. , 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[20] S. Nattel,et al. Atrial Ischemia Promotes Atrial Fibrillation in Dogs , 2003, Circulation.
[21] P. Guéret,et al. Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study. , 2003, Diabetes care.
[22] Maurizio Bentivoglio,et al. Atrial Fibrillation in Hypertension: Predictors and Outcome , 2003, Hypertension.
[23] H. Parving,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.
[24] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[25] L. Guize,et al. Cardiovascular Mortality in Hypertensive Men According to Presence of Associated Risk Factors , 2001, Hypertension.
[26] K. Borch-Johnsen,et al. Elevated Urinary Albumin Excretion Is Associated With Impaired Arterial Dilatory Capacity in Clinically Healthy Subjects , 2001, Circulation.
[27] PhilippeLechat,et al. Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial , 2001 .
[28] A. Mallet,et al. Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial , 2001, Circulation.
[29] M. Schroll,et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. , 2000, Hypertension.
[30] P A Wolf,et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.
[31] G. Kay,et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.
[32] R. Bigazzi,et al. Microalbuminuria in essential hypertension. , 1997, Journal of nephrology.
[33] M. Malik,et al. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. , 1996, Journal of the American College of Cardiology.
[34] J. Jensen,et al. Renal and systemic transvascular albumin leakage in severe atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[35] G. Dell'omo,et al. Microalbuminuria and endothelial dysfunction in essential hypertension , 1994, The Lancet.
[36] R B D'Agostino,et al. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. , 1993, American heart journal.
[37] J Ross,et al. Influence of heart rate on mortality after acute myocardial infarction. , 1990, The American journal of cardiology.
[38] K. Borch-Johnsen,et al. Albuminuria reflects widespread vascular damage , 1989, Diabetologia.
[39] S. Blair,et al. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. , 1985, American heart journal.
[40] M. Schroll,et al. Risk factors of myocardial infarction and death in men aged 50 at entry. A ten-year prospective study from the Glostrup population studies. , 1977, Danish medical bulletin.
[41] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[42] J. Mitchell,et al. HEMODYNAMIC CONSEQUENCES OF ATRIAL FIBRILLATION AT CONSTANT VENTRICULAR RATES. , 1964, The American journal of medicine.
[43] R. Levy,et al. Transient tachycardia; prognostic significance alone and in association with transient hypertension. , 1945, The Medical press of Egypt.
[44] J T Fotheringham,et al. A Case of Malignant Pleurisy , 1897, British medical journal.
[45] M. Böhm,et al. Low-grade albuminuria and cardiovascular risk , 2007, Clinical Research in Cardiology.
[46] L Guize,et al. Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. , 1999, Hypertension.